EKF Diagnostics is a global medical manufacturer of point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose and lactate. EKF also has a long history in clinical chemistry reagent manufacture in the USA.

During the COVID-19 pandemic EKF began the production of PrimeStore MTM under licence from Longhorn Vaccines and Diagnositcs in San Antonio, Texas. PrimeStore MTM is widely used in the US and Europe to neautralise viruses in patient samples.

EKF is also a distributor of the Kantaro COVID-SeroKlir antibody kits, a quantitative ELISA test. SeroKlir provides an antibody titer that determines the presence and volume of COVID-19 antibodies present in a patient.

EKF is also a distributor of COVID-SeroKlir, an ELISA based test developed by Kantaro Inc. that detects the presence of IgG antibodies and provides a precise level that can be used to benchmark patient well-being. COVID-SeroKlir received FDA Emergency Use Authorisation (EUA) in November 2020 and is also CE marked.

Point of Care

EKF Point of Care (POC) analyzers are designed for use within doctors` surgeries, clinics, hopsitals and laboratories to provide fast and accurate results at an affordable price.

Central Laboratory

EKF Central Laboratory division manufactures a wide spectrum of reagents for use in hospital laboratories across a broad portfolio of automated and semi-automated analysers.

Life Sciences

EKF Life Sciences specializes in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry.

Quality Standards

All EKF`s facilities are accredited by the international standards agencies that oversee the design and manufacture of medical devices. EKF-diagnostic GmbH and Stanbio Laboratory are both FDA registered facilities, whilst Stanbio is also accredited by the Canadian Medical Devices Conformity Assessment Scheme (CMDCAS).

Quo-Lab - Model HbA1c - Semi-Automated Desktop Point-of-Care Analyzer - Brochure

Contact supplier

Stay in the loop!